494 related articles for article (PubMed ID: 27583768)
1. Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample.
Flückiger R; Ruhrmann S; Debbané M; Michel C; Hubl D; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
J Abnorm Psychol; 2016 Oct; 125(7):923-932. PubMed ID: 27583768
[TBL] [Abstract][Full Text] [Related]
2. "Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample": Correction to Flückiger et al. (2016).
J Abnorm Psychol; 2016 Oct; 125(7):945. PubMed ID: 27732025
[TBL] [Abstract][Full Text] [Related]
3. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
[TBL] [Abstract][Full Text] [Related]
4. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
5. The Chapman psychosis-proneness scales: Consistency across culture and time.
Chan RC; Shi HS; Geng FL; Liu WH; Yan C; Wang Y; Gooding DC
Psychiatry Res; 2015 Jul; 228(1):143-9. PubMed ID: 25962355
[TBL] [Abstract][Full Text] [Related]
6. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
Brosey E; Woodward ND
Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
[TBL] [Abstract][Full Text] [Related]
7. Further examination of the factor structure of the Chapman Psychosis Proneness Scales (CPPS).
Smith EA; Bolinskey PK; Guidi JP; Myers KR; Schuder KM; James AV; Hudak DV; Sheets V
Psychiatry Res; 2016 Apr; 238():257-263. PubMed ID: 27086242
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties and validity of short forms of the Wisconsin Schizotypy Scales in two large samples.
Gross GM; Silvia PJ; Barrantes-Vidal N; Kwapil TR
Schizophr Res; 2012 Feb; 134(2-3):267-72. PubMed ID: 22189258
[TBL] [Abstract][Full Text] [Related]
9. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
[TBL] [Abstract][Full Text] [Related]
10. A Rasch analysis of three of the Wisconsin Scales of Psychosis Proneness: measurement of schizotypy.
Graves RE; Weinstein S
J Appl Meas; 2004; 5(2):160-71. PubMed ID: 15064535
[TBL] [Abstract][Full Text] [Related]
11. A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state.
Kotlicka-Antczak M; Karbownik MS; Pawełczyk A; Żurner N; Pawełczyk T; Strzelecki D; Urban-Kowalczyk M
Compr Psychiatry; 2019 Apr; 90():95-101. PubMed ID: 30831438
[TBL] [Abstract][Full Text] [Related]
12. The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter.
Flückiger R; Michel C; Grant P; Ruhrmann S; Vogeley K; Hubl D; Schimmelmann BG; Klosterkötter J; Schmidt SJ; Schultze-Lutter F
Schizophr Res; 2019 Aug; 210():188-196. PubMed ID: 30683524
[TBL] [Abstract][Full Text] [Related]
13. [Psychometric properties of the French versions of the Cognitive Slippage Scale and Schizotypal Ambivalence Scale in 340 subjects].
Yon V; Loas G; Monestes JL; Verrier A; Deligne H
Encephale; 2007; 33(3 Pt 1):249-55. PubMed ID: 17675920
[TBL] [Abstract][Full Text] [Related]
14. Follow-up factor structure of schizotypy and its clinical associations in a help-seeking sample meeting ultra-high risk for psychosis criteria at baseline.
Lin A; Wigman JT; Nelson B; Wood SJ; Vollebergh WA; van Os J; Yung AR
Compr Psychiatry; 2013 Feb; 54(2):173-80. PubMed ID: 22901838
[TBL] [Abstract][Full Text] [Related]
15. Developing psychosis and its risk states through the lens of schizotypy.
Debbané M; Eliez S; Badoud D; Conus P; Flückiger R; Schultze-Lutter F
Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S396-407. PubMed ID: 25548386
[TBL] [Abstract][Full Text] [Related]
16. Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.
Chan CC; Bulbena-Cabre A; Rutter S; Benavides C; McClure MM; Calabrese W; Rosell DR; Koenigsberg HW; Goodman M; New AS; Hazlett EA; Mercedes Perez-Rodriguez M
Schizophr Res; 2019 Jul; 209():263-268. PubMed ID: 30635257
[TBL] [Abstract][Full Text] [Related]
17. Cortical Suppression to Delayed Self-Initiated Auditory Stimuli in Schizotypy: Neurophysiological Evidence for a Continuum of Psychosis.
Oestreich LK; Mifsud NG; Ford JM; Roach BJ; Mathalon DH; Whitford TJ
Clin EEG Neurosci; 2016 Jan; 47(1):3-10. PubMed ID: 25898988
[TBL] [Abstract][Full Text] [Related]
18. Schizotypy: phenotypic marker as risk factor.
Catts SV; Fox AM; Ward PB; McConaghy N
Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S101-7. PubMed ID: 11129293
[TBL] [Abstract][Full Text] [Related]
19. Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms.
Barrantes-Vidal N; Gross GM; Sheinbaum T; Mitjavila M; Ballespí S; Kwapil TR
Schizophr Res; 2013 Apr; 145(1-3):50-5. PubMed ID: 23402694
[TBL] [Abstract][Full Text] [Related]
20. Individuals with psychometric schizotypy show similar social but not physical anhedonia to patients with schizophrenia.
Wang Y; Lui SS; Zou LQ; Zhang Q; Zhao Q; Yan C; Hong XH; Tan SP; Cheung EF; Chan RC
Psychiatry Res; 2014 May; 216(2):161-7. PubMed ID: 24589449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
